Industry recognition reflects continuous joint investment that unites Armis Centrix™, the Armis Cyber Exposure Management Platform, with Elisity’s dynamic microsegmentation platform, widening clinical attack surface management and tightening policy control across Main Line Health’s network
Armis, the cyber exposure management & security company, and Elisity, a pioneer in identity-based microsegmentation, announced the results driven by their strategic integration that delivers frictionless, centrally managed Zero Trust access across enterprise networks. With this, both companies would like to congratulate their joint customer Main Line Health, which recently earned the prestigious CIO 100 Award for 2025, following their CSO50 Award in 2024, for their innovative cybersecurity implementation leveraging both platforms.
Health Technology Insights: Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines
“The synergy between Armis and Elisity has fortified defenses against targeted cyber threats, improving overall operational efficiency with added layers of security and visibility,” said Aaron Weismann, Chief Information Security Officer for Main Line Health, whose team earned both awards for their innovative cybersecurity work. “Microsegmentation is a key strategy for accelerating our Zero Trust program.”
Aaron Weismann will be sharing Main Line Health’s innovative approaches to cybersecurity at the upcoming RSA Conference (RSAC 2025) in San Francisco. His session, “Dr. Darkness or: How We Learned to Stop Worrying and Love Downtimes” (Thursday, May 1, 8:30 AM – 9:20 AM PDT), will explore the organization’s innovative approach to maintaining clinical operations during cyber disruptions. The session, which also features Main Line Health Program Manager Anthony Fiore, will highlight how solutions like the Armis and Elisity integration help healthcare organizations enhance cyber resilience.
The integration provides visibility and control over the entire attack surface, enabling organizations to rapidly implement microsegmentation and prevent lateral movement attacks—the technique used in over 70% of successful breaches, according to recent industry reports.
Health Technology Insights: Lyra Health Unveils AI Platform to Build Workforce Resilience
This powerful combination addresses the critical challenges faced by manufacturing, healthcare, and industrial organizations as cyber attackers increasingly target unprotected east-west traffic across IT, IoT, OT, and IoMT devices. According to Forrester Research, microsegmentation has entered its “Golden Age” as a crucial strategy for preventing lateral movement, with research showing organizations implementing comprehensive microsegmentation solutions achieve $3.50 in value for every dollar invested.
“By integrating the extensive cyber exposure management capabilities of Armis Centrix™ with Elisity’s dynamic policy engine, we’re advancing network-segmentation architecture for enterprises pursuing Zero Trust maturity,” said James Winebrenner, CEO of Elisity. “Organizations can now implement comprehensive microsegmentation in weeks instead of years, rapidly discovering every user, workload, and device on their networks and automating policies that persist wherever those devices appear.”
“Supporting our customers in solving their toughest cybersecurity challenges is our top priority,” said Nadir Izrael, CTO and Co-Founder of Armis. “The opportunity to come together with industry peers, like Elisity, to integrate our solutions to work better together on behalf of customers makes that mission even more impactful and rewarding. We’re proud of our collaboration on behalf of Main Line Health and we will continue to support them as they advance patient safety and drive operational resilience.”
Teddie Wardi, Managing Director at Insight Partners, which holds investments in both companies, added, “We’ve seen firsthand how microsegmentation projects often falter due to implementation challenges. This partnership between Armis and Elisity addresses this market gap by delivering a solution that can be quickly and effectively implemented and scaled across thousands of IT and OT environments. The combination of comprehensive cyber exposure management with identity-based microsegmentation creates immediate value for enterprises seeking to enhance their security posture.”
The successful deployment at Main Line Health underscores the deepening strategic integration between Armis and Elisity, focused on collaborating to address critical enterprise security gaps. This integration represents a significant joint investment, uniting Armis’ leadership in cyber exposure management with Elisity’s leading identity-based microsegmentation to deliver a powerful framework for organizations pursuing Zero Trust maturity. Both companies are committed to continued collaboration to enhance security postures for joint customers facing increasingly complex threats.
This bidirectional integration works by synchronizing Armis’ comprehensive asset intelligence and risk quantification with Elisity’s identity-based microsegmentation and dynamic policy engine, the integration provides enhanced situational awareness and enables the enforcement of least-privilege access policies crucial for protecting complex environments.
Health Technology Insights: Principle Health Systems Acquires Heartland Health Laboratory
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
